Office For Life Sciences
October 31
00:01
2024
class="gem-c-govspeak govuk-govspeak gem-c-govspeak--direction-ltr govuk-!-margin-bottom-0">
31 October 2024: update
The Life Sciences Innovative Manufacturing Fund (LSIMF) is open and will accept Expression of Interests (EOI) on a rolling basis.
The governments plan for Life Sciences A Prescription for Growth committed up to 520 million for life sciences manufacturing, to help deliver on the governments missions to kickstart economic growth and build an NHS fit for the future.
The LSIMF will be UK and sector wide and will provide capital grants for investments in the manufacture of:
- Human medicines (this includes both the manufacture of active pharmaceutical ingredients (API) / drug substance and finished product / drug product).
- Medical diagnostics for both disease identification and monitoring.
- MedTech products all types of medical devices related to human health.
This guidance includes information about LSIMF and the application process.